Direkt zum Inhalt
Merck
  • Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.

Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells.

Journal of immunology (Baltimore, Md. : 1950) (2004-08-24)
Nadia Duarte, Martin Stenström, Susana Campino, Marie-Louise Bergman, Marie Lundholm, Dan Holmberg, Susanna L Cardell
ZUSAMMENFASSUNG

A role for regulatory lymphocytes has been demonstrated in the pathogenesis of type 1 diabetes in the NOD mouse but the nature of these cells is debated. CD1d-restricted NKT lymphocytes have been implicated in this process. Previous reports of reduced diabetes incidence in NOD mice in which the numbers of NKT cells are artificially increased have been attributed to the enhanced production of IL-4 by these cells and a role for classical NKT cells, using the Valpha14-Jalpha18 rearrangement. We now show that overexpression in NOD mice of CD1d-restricted TCR Valpha3.2(+)Vbeta9(+) NKT cells producing high levels of IFN-gamma but low amounts of IL-4 leads to prevention of type 1 diabetes, demonstrating a role for nonclassical CD1d-restricted NKT cells in the regulation of autoimmune diabetes.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-CD4 Antibody (mouse), clone GK1.5, clone GK1.5, 0.5 mg/mL, from rat